Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.39 |
| ▸ | RIPK2 | O43353 | 3/20 | 0.38 |
| ▸ | RIPK3 | Q9Y572 | 3/20 | 0.38 |
| ▸ | TRPM5 | Q9NZQ8 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29457651 | 1.00 | ALDH1A1 (0.50) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL9143839 | 0.85 | RAB9A (0.44) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL11213454 | 0.85 | RIPK3 (0.38) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL14127237 | 0.83 | NPC1 (0.54) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL10543 | 0.83 | NPC1 (0.54) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL9300561 | 0.81 | NPC1 (0.44) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| Hydrazine SCHEMBL27534766 | 0.79 | NPC1 (0.51) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL28048502 | 0.77 | ALDH1A1 (0.54) | ALDH1A1HSD17B10EGFRNPC1RAB9A | |
| SCHEMBL31514631 | 0.76 | EGFR (0.69) | EGFRRIPK2RIPK3RIPK1 | |
| SCHEMBL9676880 | 0.75 | ALDH1A1 (0.47) | ALDH1A1HSD17B10EGFRNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120004820-A | CO utilization2Preparation of benzothiazoles method for preparing compounds | 内蒙古工业大学 | 2025-05-16 | — | — | CN | claimed |
| CN-117945995-A | Alkylated nitrogen-containing heterocyclic compound and preparation method and application thereof | 中国科学院青海盐湖研究所 | 2024-04-30 | — | — | CN | claimed |
| CN-115433072-B | Method for preparing aryl ketone by photocatalytic oxidation | 浙江工业大学 | 2023-08-08 | — | — | CN | claimed |
| CN-115504942-A | Synthesis method of alkyl or acyl substituted benzothiazole derivative | 汕头大学 | 2022-12-23 | — | — | CN | claimed |
| CN-115433072-A | Method for preparing aryl ketone by photocatalytic oxidation | 浙江工业大学 | 2022-12-06 | — | — | CN | claimed |
| CN-113045993-A | Polishing solution for processing ultra-smooth low-damage bearing steel surface and application thereof | 西南交通大学 | 2021-06-29 | — | — | CN | claimed |
| CN-106432132-A | Preparation method of 2-arylbenzothiazole compound | 西北师范大学 | 2017-02-22 | — | — | CN | claimed |
| CN-102408394-A | 2-ethylthio-5-bromobenzothiazole and preparation method and application thereof | UNIV ZHEJIANG | 2012-04-11 | — | — | CN | claimed |
| CN-102010385-A | Preparation method of 2-methylthio-5-benzothiazole | UNIV ZHEJIANG | 2011-04-13 | — | — | CN | claimed |
| EP-0271260-B1 | Supersensitization of silver halide emulsions | MINNESOTA MINING & MFG (US) | 1995-01-04 | — | — | EP | claimed |
| US-4891305-A | LASERS | RICOH CO., LTD. (JP) | 1990-01-02 | — | — | US | claimed |
| US-4889796-A | CONTAINING BENZOXAZOLE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-26 | — | — | US | claimed |
| US-4873184-A | ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-10 | — | — | US | claimed |
| EP-0271260-A2 | Supersensitization of silver halide emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| US-4102688-A | CONTAINING PYRAZOLO(3,4-B)PYRIDINE/3,6-DIONE MOIETY | FUJI PHOTO FILM CO., LTD. (JP) | 1978-07-25 | — | — | US | claimed |
| US-3970461-A | Fogged, direct-positive silver halide emulsion containing carbocyanine dye having indolenine nucleus | FUJI PHOTO FILM CO., LTD. (JA) | 1976-07-20 | — | — | US | claimed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12570621-B2 | Short-acting 3,4-methylenedioxymethamphetamine (MDMA) analogs incorporating benzothiazole | APOAPSIS HOLDINGS, LLC (US) | 2026-03-10 | — | — | US | disclosed |
| US-3936308-A | Photographic emulsions containing methine dyes having a 1H-imidazo[4,5-b]pyrazine nucleus | EASTMAN KODAK COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
| US-3935010-A | IMIDAZOQUINOXALINE DESENSITIZER | EASTMAN KODAK COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570621-B2 | Short-acting 3,4-methylenedioxymethamphetamine (MDMA) analogs incorporating benzothiazole | SLC6A3, SLC6A2, HTR2C | ALDH1A1 1951/4885HSD17B10 1783/4885EGFR 1574/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | ALDH1A1 100/4885HSD17B10 410/4885EGFR 383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.